The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy
Not yet recruitingOBSERVATIONAL
Enrollment
105
Participants
Timeline
Start Date
October 15, 2025
Primary Completion Date
August 31, 2029
Study Completion Date
August 31, 2029
Conditions
Duchenne Muscular Dystrophy (DMD)
All Listed Sponsors
collaborator
United States Department of Defense
FED
lead
University of Rochester
OTHER
NCT07092540 - The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy | Biotech Hunter | Biotech Hunter